For research and educational purposes only. Not medical advice.
AOD-9604 Reference
Educational, not medical advice reference for AOD-9604: Fat Loss; regulatory status, evidence posture, source review, and schedule notes. Also known as hGH f…
Reference summary
Human development reached multiple obesity studies with no major safety signal highlighted in sponsor protocol history, but efficacy was not sufficient for approval. Current use is research or gray-market marketing, not an approved obesity therapy.
- Categories
- Fat Loss
- Aliases
- hGH fragment 176-191 analog, AOD
- Evidence posture
- human — Human trials did not support obesity approval.
- Regulatory status
- No FDA-approved AOD-9604 drug label. Sponsor protocol documents for LAT8881/AOD9604 state obesity development was discontinued after the most recent efficacy study failed its primary endpoint. FDA lists AOD-9604 among bulk substances with safety-risk concerns.
- Content review status
- research reference